Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Global Sodium Heparin market is projected to reach US$ 2423 million in 2029, increasing from US$ 1948 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Heparin market research.
Global Heparin Sodium key players include Shenzhen Hepalink, Bioibérica, Nanjing King-friend, Pfizer, Dongcheng Biochemicals, etc. Global top five manufacturers hold a share about 60%. China is the largest market, with a share about 60%, followed by Europe and North America, total with a share about 37 percent. In terms of application, the largest application is Treatment of Venous Thromboembolism, followed by Cardioversion of Atrial Fibrillation/Flutter, and Treatment of Venous Thromboembolism, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sodium Heparin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company (Partial List)
Segment by Type
Segment by Application
Production by Region
Consumption by Region
The Sodium Heparin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
1 Sodium Heparin Market Overview
1.1 Product Definition
1.2 Sodium Heparin Segment by Type
1.2.1 Global Sodium Heparin Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Sodium Heparin Segment by Application
1.3.1 Global Sodium Heparin Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Sodium Heparin Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Sodium Heparin Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Sodium Heparin Production Estimates and Forecasts (2018-2029)
1.4.4 Global Sodium Heparin Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Sodium Heparin Production Market Share by Manufacturers (2018-2023)
2.2 Global Sodium Heparin Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Sodium Heparin, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Sodium Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Sodium Heparin Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Sodium Heparin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Sodium Heparin, Product Offered and Application
2.8 Global Key Manufacturers of Sodium Heparin, Date of Enter into This Industry
2.9 Sodium Heparin Market Competitive Situation and Trends
2.9.1 Sodium Heparin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Sodium Heparin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Sodium Heparin Production by Region
3.1 Global Sodium Heparin Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Sodium Heparin Production Value by Region (2018-2029)
3.2.1 Global Sodium Heparin Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Sodium Heparin by Region (2024-2029)
3.3 Global Sodium Heparin Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Sodium Heparin Production by Region (2018-2029)
3.4.1 Global Sodium Heparin Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Sodium Heparin by Region (2024-2029)
3.5 Global Sodium Heparin Market Price Analysis by Region (2018-2023)
3.6 Global Sodium Heparin Production and Value, Year-over-Year Growth
3.6.1 North America Sodium Heparin Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Sodium Heparin Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Sodium Heparin Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Sodium Heparin Production Value Estimates and Forecasts (2018-2029)
4 Sodium Heparin Consumption by Region
4.1 Global Sodium Heparin Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Sodium Heparin Consumption by Region (2018-2029)
4.2.1 Global Sodium Heparin Consumption by Region (2018-2023)
4.2.2 Global Sodium Heparin Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Sodium Heparin Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Sodium Heparin Consumption by Country (2018-2029)
4.4 Europe
4.4.1 Europe Sodium Heparin Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Sodium Heparin Consumption by Country (2018-2029)
4.5 Asia Pacific
4.5.1 Asia Pacific Sodium Heparin Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Sodium Heparin Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Sodium Heparin Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Sodium Heparin Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Sodium Heparin Production by Type (2018-2029)
5.1.1 Global Sodium Heparin Production by Type (2018-2023)
5.1.2 Global Sodium Heparin Production by Type (2024-2029)
5.1.3 Global Sodium Heparin Production Market Share by Type (2018-2029)
5.2 Global Sodium Heparin Production Value by Type (2018-2029)
5.2.1 Global Sodium Heparin Production Value by Type (2018-2023)
5.2.2 Global Sodium Heparin Production Value by Type (2024-2029)
5.2.3 Global Sodium Heparin Production Value Market Share by Type (2018-2029)
5.3 Global Sodium Heparin Price by Type (2018-2029)
6 Segment by Application
6.1 Global Sodium Heparin Production by Application (2018-2029)
6.1.1 Global Sodium Heparin Production by Application (2018-2023)
6.1.2 Global Sodium Heparin Production by Application (2024-2029)
6.1.3 Global Sodium Heparin Production Market Share by Application (2018-2029)
6.2 Global Sodium Heparin Production Value by Application (2018-2029)
6.2.1 Global Sodium Heparin Production Value by Application (2018-2023)
6.2.2 Global Sodium Heparin Production Value by Application (2024-2029)
6.2.3 Global Sodium Heparin Production Value Market Share by Application (2018-2029)
6.3 Global Sodium Heparin Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Shenzhen Hepalink
7.1.1 Shenzhen Hepalink Sodium Heparin Corporation Information
7.1.2 Shenzhen Hepalink Sodium Heparin Product Portfolio
7.1.3 Shenzhen Hepalink Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Shenzhen Hepalink Main Business and Markets Served
7.1.5 Shenzhen Hepalink Recent Developments/Updates
7.2 Bioibérica
7.2.1 Bioibérica Sodium Heparin Corporation Information
7.2.2 Bioibérica Sodium Heparin Product Portfolio
7.2.3 Bioibérica Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Bioibérica Main Business and Markets Served
7.2.5 Bioibérica Recent Developments/Updates
7.3 Nanjing King-friend
7.3.1 Nanjing King-friend Sodium Heparin Corporation Information
7.3.2 Nanjing King-friend Sodium Heparin Product Portfolio
7.3.3 Nanjing King-friend Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Nanjing King-friend Main Business and Markets Served
7.3.5 Nanjing King-friend Recent Developments/Updates
7.4 Pfizer
7.4.1 Pfizer Sodium Heparin Corporation Information
7.4.2 Pfizer Sodium Heparin Product Portfolio
7.4.3 Pfizer Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Pfizer Main Business and Markets Served
7.4.5 Pfizer Recent Developments/Updates
7.5 Dongcheng Biochemicals
7.5.1 Dongcheng Biochemicals Sodium Heparin Corporation Information
7.5.2 Dongcheng Biochemicals Sodium Heparin Product Portfolio
7.5.3 Dongcheng Biochemicals Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Dongcheng Biochemicals Main Business and Markets Served
7.5.5 Dongcheng Biochemicals Recent Developments/Updates
7.6 Changzhou Qianhong Bio-pharma
7.6.1 Changzhou Qianhong Bio-pharma Sodium Heparin Corporation Information
7.6.2 Changzhou Qianhong Bio-pharma Sodium Heparin Product Portfolio
7.6.3 Changzhou Qianhong Bio-pharma Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Changzhou Qianhong Bio-pharma Main Business and Markets Served
7.6.5 Changzhou Qianhong Bio-pharma Recent Developments/Updates
7.7 Changshan Biochemical
7.7.1 Changshan Biochemical Sodium Heparin Corporation Information
7.7.2 Changshan Biochemical Sodium Heparin Product Portfolio
7.7.3 Changshan Biochemical Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Changshan Biochemical Main Business and Markets Served
7.7.5 Changshan Biochemical Recent Developments/Updates
7.8 Pharma Action
7.8.1 Pharma Action Sodium Heparin Corporation Information
7.8.2 Pharma Action Sodium Heparin Product Portfolio
7.8.3 Pharma Action Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Pharma Action Main Business and Markets Served
7.7.5 Pharma Action Recent Developments/Updates
7.9 Baxter
7.9.1 Baxter Sodium Heparin Corporation Information
7.9.2 Baxter Sodium Heparin Product Portfolio
7.9.3 Baxter Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Baxter Main Business and Markets Served
7.9.5 Baxter Recent Developments/Updates
7.10 Dongying Tiandong Pharmaceutical
7.10.1 Dongying Tiandong Pharmaceutical Sodium Heparin Corporation Information
7.10.2 Dongying Tiandong Pharmaceutical Sodium Heparin Product Portfolio
7.10.3 Dongying Tiandong Pharmaceutical Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Dongying Tiandong Pharmaceutical Main Business and Markets Served
7.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
7.11 Opocrin
7.11.1 Opocrin Sodium Heparin Corporation Information
7.11.2 Opocrin Sodium Heparin Product Portfolio
7.11.3 Opocrin Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Opocrin Main Business and Markets Served
7.11.5 Opocrin Recent Developments/Updates
7.12 Aspen Oss
7.12.1 Aspen Oss Sodium Heparin Corporation Information
7.12.2 Aspen Oss Sodium Heparin Product Portfolio
7.12.3 Aspen Oss Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Aspen Oss Main Business and Markets Served
7.12.5 Aspen Oss Recent Developments/Updates
7.13 Xinbai Pharmaceuticals
7.13.1 Xinbai Pharmaceuticals Sodium Heparin Corporation Information
7.13.2 Xinbai Pharmaceuticals Sodium Heparin Product Portfolio
7.13.3 Xinbai Pharmaceuticals Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Xinbai Pharmaceuticals Main Business and Markets Served
7.13.5 Xinbai Pharmaceuticals Recent Developments/Updates
7.14 Yino Pharma Limited
7.14.1 Yino Pharma Limited Sodium Heparin Corporation Information
7.14.2 Yino Pharma Limited Sodium Heparin Product Portfolio
7.14.3 Yino Pharma Limited Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Yino Pharma Limited Main Business and Markets Served
7.14.5 Yino Pharma Limited Recent Developments/Updates
7.15 Sichuan Deebio
7.15.1 Sichuan Deebio Sodium Heparin Corporation Information
7.15.2 Sichuan Deebio Sodium Heparin Product Portfolio
7.15.3 Sichuan Deebio Sodium Heparin Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Sichuan Deebio Main Business and Markets Served
7.15.5 Sichuan Deebio Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Sodium Heparin Industry Chain Analysis
8.2 Sodium Heparin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Sodium Heparin Production Mode & Process
8.4 Sodium Heparin Sales and Marketing
8.4.1 Sodium Heparin Sales Channels
8.4.2 Sodium Heparin Distributors
8.5 Sodium Heparin Customers
9 Sodium Heparin Market Dynamics
9.1 Sodium Heparin Industry Trends
9.2 Sodium Heparin Market Drivers
9.3 Sodium Heparin Market Challenges
9.4 Sodium Heparin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research